These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19908116)

  • 1. Emergent coronary artery bypass grafting for cardiogenic shock caused by very late drug-eluting stent thrombosis.
    Boffini M; Ceresa F; Sansone F; Ribezzo M; Comoglio C; Rinaldi M
    Gen Thorac Cardiovasc Surg; 2009 Nov; 57(11):609-11. PubMed ID: 19908116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very late stent thrombosis: simultaneous two-arterial occlusions.
    Vaknin-Assa H; Iakobishvili Z; Kornowski R
    Cardiovasc Revasc Med; 2008; 9(4):281-3. PubMed ID: 18928956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extremely late drug-eluting stent thrombosis: 2037 days after deployment.
    Layland J; Jellis C; Whitbourn R
    Cardiovasc Revasc Med; 2009; 10(1):55-7. PubMed ID: 19159856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.
    Al-Dehneh A; Virk H; Alkhouri Y; Hamdan A; Bikkina M
    Tex Heart Inst J; 2010; 37(3):343-6. PubMed ID: 20548819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve months clinical outcome of drug-eluting stents implantation or coronary artery bypass surgery for the treatment of diabetic patients with multivessel disease.
    Qiao Y; Ma C; Nie S; Liu X; Kang J; Lv Q; Du X; Hu R; Zhang Y; Jia C; Liu X; Dong J; Chen F; Zhou Y; Lv S; Huang F; Gu C; Wu X
    Clin Cardiol; 2009 Aug; 32(8):E24-30. PubMed ID: 19455692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes after angiographically defined very late stent thrombosis of drug-eluting stent.
    Kim U; Kim DK; Kim YB; Seol SH; Yang TH; Kim DK; Kim DI; Kim DS; Lee SH; Hong GR; Park JS; Shin DG; Kim YJ; Cho YK; Kim HS; Nam CW; Hur SH; Kim KB
    Clin Cardiol; 2009 Sep; 32(9):526-9. PubMed ID: 19743488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent thrombosis with an aneurysm 7 years after a drug eluting stent implantation.
    Patil P; Sethi A; Kaul U
    Indian Heart J; 2014; 66(2):216-9. PubMed ID: 24814120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.
    Murray AT; Sederberg JH
    Semin Cardiothorac Vasc Anesth; 2011; 15(1-2):40-3. PubMed ID: 21840879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous late stent thrombosis in two coronary arteries following drug-eluting stent implantation.
    Prasad SB; Malaiapan Y; Ahmar W; Meredith IT
    Cardiovasc Revasc Med; 2009; 10(3):188-90. PubMed ID: 19595402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid revascularization, comprising coronary artery bypass graft with exclusive arterial conduits followed by early drug-eluting stent implantation, in multivessel coronary artery disease.
    Delhaye C; Sudre A; Lemesle G; Vanesson L; Koussa M; Fayad G; Bauters C; Lablanche JM; Modine T
    Arch Cardiovasc Dis; 2010 Oct; 103(10):502-11. PubMed ID: 21130963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary clinical characteristics, treatment, and outcomes of angiographically confirmed coronary stent thrombosis: results from a multicenter California registry.
    Yeo KK; Mahmud E; Armstrong EJ; Bennett WE; Shunk KA; MacGregor JS; Li Z; Low RI; Rogers JH
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):550-6. PubMed ID: 21563289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes with 6 months dual antiplatelet therapy after implantation of biolimus-A9 drug eluting coronary stents.
    Cockburn J; Pareek N; Poliacikova P; Saraf S; Williams R; Dhillon G; Robinson D; Gerber R; Hatrick R; Blows L; de Belder A; Hildick-Smith D
    Int J Cardiol; 2014 Mar; 172(1):185-9. PubMed ID: 24462139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Cheong SS; Kim JJ; Park SW; Park SJ
    JACC Cardiovasc Interv; 2008 Oct; 1(5):494-503. PubMed ID: 19463351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease.
    Yang JH; Gwon HC; Cho SJ; Hahn JY; Choi JH; Choi SH; Lee YT; Lee SH; Hong KP; Park JE
    Ann Thorac Surg; 2008 Jan; 85(1):65-70. PubMed ID: 18154782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS.
    Jakabcin J; Spacek R; Bystron M; Kvasnák M; Jager J; Veselka J; Kala P; Cervinka P
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):578-83. PubMed ID: 19902491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.